Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction

BACKGROUND A technical advance in contrast-enhanced magnetic resonance imaging (MRI) has significantly improved image quality. We investigated whether healed myocardial infarction can be visualised as hyperenhanced regions with this new technique, and whether assessment of the transmural extent of infarction yields new physiological data. METHODS 82 MRI examinations were carried out in three groups: patients with healed myocardial infarction; patients with non-ischaemic cardiomyopathy; and healthy volunteers. Patients with healed myocardial infarction were prospectively enrolled after enyzmatically proven necrosis and imaged 3 months (SD 1) or 14 months (7) later. The MRI procedure used a segmented inversion-recovery gradient-echo sequence after gadolinium administration. Findings were compared with those of coronary angiography, electrocardiography, cine MRI, and creatine kinase measurements. FINDINGS 29 (91%) of 32 patients with infarcts imaged at 3 months (13 non-Q-wave) and all of 19 imaged at 14 months (eight non-Q-wave) showed hyperenhancement. In patients in whom the infarct-related-artery was identified by angiography, 24 of 25 imaged at 3 months and all of 14 imaged at 14 months had hyperenhancement in the appropriate territory. None of the 20 patients with non-ischaemic cardiomyopathy or the 11 healthy volunteers showed hyperenhancement. Irrespective of the presence or absence of Q waves, the majority of patients with hyperenhancement had only non-transmural involvement. Normal left-ventricular contraction was shown in seven patients examined at 3 months and three examined at 14 months, but in these cases hyperenhancement was limited to the subendocardium. INTERPRETATION The presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction can be accurately determined by contrast-enhanced MRI.

[1]  J. Neaton,et al.  Unrecognized myocardial infarction: experience in the multiple risk factor intervention trial (MRFIT) , 1987, Circulation.

[2]  R O Bonow,et al.  Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.

[3]  T D Miller,et al.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. , 2000, Circulation.

[4]  B. McManus,et al.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. , 1987, The American journal of cardiology.

[5]  J. Alpert,et al.  Non-Q wave myocardial infarction: recent changes in occurrence and prognosis--a community-wide perspective. , 1987, American heart journal.

[6]  W. L. Ooi,et al.  Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study. , 1990, The American journal of cardiology.

[7]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[8]  R. Testa,et al.  Myocardial Blood Flow Distribution in Patients With Ischemic Heart Disease or Dilated Cardiomyopathy Undergoing Heart Transplantation , 1993, Circulation.

[9]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[10]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[11]  J. Weiss,et al.  Two‐dimensional Echocardiographic Recognition of Myocardial Injury in Man: Comparison with Postmortem Studies , 1981, Circulation.

[12]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[13]  H. Weinmann,et al.  Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.

[14]  O Strohm,et al.  Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.

[15]  B. Gersh,et al.  Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly. , 2000, Journal of the American College of Cardiology.

[16]  S. M. Collins,et al.  Myocardial infarct size threshold for two-dimensional echocardiographic detection: sensitivity of systolic wall thickening and endocardial motion abnormalities in small versus large infarcts. , 1985, The American journal of cardiology.

[17]  W. Kannel,et al.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[18]  S. Kaul Assessing the myocardium after attempted reperfusion: should we bother? , 1998, Circulation.

[19]  P. V. van Dijkman,et al.  Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. , 1991, Radiology.

[20]  R. Kim,et al.  Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. , 2000, Journal of the American College of Cardiology.

[21]  R. Kleiger,et al.  Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction☆ , 1990 .

[22]  E. Gilpin,et al.  Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. , 1989, Circulation.

[23]  F. Fedele,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging. , 1994, American heart journal.

[24]  B. Gersh,et al.  Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.

[25]  M. Verani,et al.  Quantification of infarct size by 201Tl single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates. , 1988, Circulation.

[26]  B. Jugdutt,et al.  Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. , 1986, Journal of the American College of Cardiology.

[27]  O. Simonetti,et al.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.

[28]  N. Yamada,et al.  Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. , 1989, AJR. American journal of roentgenology.